The Potential of iPS Cells in Synucleinopathy Research
Joint Authors
Linta, Leonhard
Liebau, Stefan
Kleger, Alexander
Stockmann, Marianne
Boeckers, Tobias M.
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-03-18
Country of Publication
Egypt
No. of Pages
6
Abstract EN
α-synuclein is a protein involved in the pathogenesis of several so-called synucleinopathies including Parkinson's disease.
A variety of models have been so far assessed.
Human induced pluripotent stem cells provide a patient- and disease-specific model for in vitro studies, pharmacotoxicological screens, and hope for future cell-based therapies.
Initial experimental procedures include the harvest of patients’ material for the reprogramming process, the investigation of the patients genetic background in the cultured cells, and the evaluation of disease-relevant factors/proteins under various cell culture conditions.
American Psychological Association (APA)
Linta, Leonhard& Stockmann, Marianne& Boeckers, Tobias M.& Kleger, Alexander& Liebau, Stefan. 2012. The Potential of iPS Cells in Synucleinopathy Research. Stem Cells International،Vol. 2012, no. 2012, pp.1-6.
https://search.emarefa.net/detail/BIM-1030034
Modern Language Association (MLA)
Linta, Leonhard…[et al.]. The Potential of iPS Cells in Synucleinopathy Research. Stem Cells International No. 2012 (2012), pp.1-6.
https://search.emarefa.net/detail/BIM-1030034
American Medical Association (AMA)
Linta, Leonhard& Stockmann, Marianne& Boeckers, Tobias M.& Kleger, Alexander& Liebau, Stefan. The Potential of iPS Cells in Synucleinopathy Research. Stem Cells International. 2012. Vol. 2012, no. 2012, pp.1-6.
https://search.emarefa.net/detail/BIM-1030034
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1030034